The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,102,455 in first-year total cost, median $237,750.
Most frequent study sections
- Drug Discovery for the Nervous System Study Section[DDNS]9
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- KECK GRADUATE INST OF APPLIED LIFE SCIS1
- LANKENAU INSTITUTE FOR MEDICAL RESEARCH1
- LIFESPLICE PHARMA, LLC1
- PURDUE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Exploring irisin as a novel target for Alzheimer's Disease1R21AG062904-01 | CHOI, SE HOONWRANN, CHRISTIANE D. | MASSACHUSETTS GENERAL HOSPITAL, MA | $252,000 | DDNS |
| 2019 | Assay development and screening for small molecule RGS10 regulators to target neuroinflammation1R21AG064416-01 | HOOKS, SHELLEY BSJOGREN, BENITA JENNY | PURDUE UNIVERSITY, IN | $238,574 | DDNS |
| 2019 | Therapeutic Intervention to activate Nrf2 in Alzheimers1R21AG061689-01 | MERALI, SALIM | TEMPLE UNIV OF THE COMMONWEALTH, PA | $237,750 | DDNS |
| 2018 | Development of Splice Modulating Oligonucleotides Targeting RAGE as a Treatment for Alzheimer's Disease1R21AG060208-01 | TALLENT, MELANIE K | LIFESPLICE PHARMA, LLC, PA | $245,000 | DDNS |
| 2018 | Development of brain-penetrant HDAC6-selective inhibitors1R21MH111723-01A1 | WANG, CHANGNING | MASSACHUSETTS GENERAL HOSPITAL, MA | $208,228 | DDNS |
| 2017 | New Drug Discovery Paradigms for Synucleinopathies1R21AG055047-01A1 | BORCHELT, DAVID RREICHMAN, MELVIN | LANKENAU INSTITUTE FOR MEDICAL RESEARCH, PA | $258,676 | DDNS |
| 2017 | Small molecule neurotrophin receptor ligands to treat Alzheimer's disease1R21AG053856-01A1 | LONGO, FRANK M | STANFORD UNIVERSITY, CA | $237,671 | DDNS |
| 2017 | Scaffold Discovery for Caspase-2 by Fragment Screening1R21AG055037-01 | WALTERS, MICHAEL A. | UNIVERSITY OF MINNESOTA, MN | $229,125 | DDNS |
| 2017 | Re-engineering Erythropoietin for Alzheimer's Disease1R21AG055949-01 | SUMBRIA, RACHITA | KECK GRADUATE INST OF APPLIED LIFE SCIS, CA | $195,431 | DDNS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.